InfuSystem Holdings (NASDAQ:INFU) CEO Eric K. Steen acquired 15,100 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average cost of $2.73 per share, with a total value of $41,223.00. Following the completion of the purchase, the chief executive officer now directly owns 109,953 shares of the company’s stock, valued at approximately $300,172. InfuSystem Holdings, Inc. (NYSEMKT:INFU) in last trading activity advanced 14.39% to close at $3.18. Company weekly performance is 16.06% while its quarterly performance stands at 6.71%. InfuSystem Holdings, Inc. (NYSEMKT:INFU) is -29.33% away from its 52 week high.
The world’s largest mobile chipset developer, Qualcomm Inc. (NASDAQ:QCOM), has added another feather to its cap. The company has expanded its LTE capabilities in Snapdragon 810 with the processor now offering support for LTE Category 9 carrier aggregation. The processor will thus allow compatible devices to download at top speeds of 450 Mbps, up from the current peak data rates of 300 Mbps. On last trading day QUALCOMM, Inc. (NASDAQ:QCOM) advanced 0.10% to close at $73.43. Its volatility for the week is 2.01% while volatility for the month is 1.78%. QCOM’s sales growth for past 5 years was 20.60% and its EPS growth for past 5 years was 32.70%. QUALCOMM, Inc. (NASDAQ:QCOM) monthly performance is 4.81%.
Six Flags Entertainment Corp (NYSE:SIX) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research note issued on Thursday. The firm currently has a $41.10 price objective on the stock. On last trading day Six Flags Entertainment Corporation (NYSE:SIX) fell -0.05% to close at $41.95. Its volatility for the week is 1.98% while volatility for the month is 1.94%. SIX’s sales growth for past 5 years was 2.00% and its EPS growth for past 5 years was 42.20%. Six Flags Entertainment Corporation (NYSE:SIX) monthly performance is 5.96%.
British drugmaker AstraZeneca PLC (NYSE:AZN) said Friday that the US Food and Drug Administration has approved Lynparza capsules, 400mg twice daily, as the first monotherapy for patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer, who have been treated with three or more prior lines of chemotherapy. AstraZeneca PLC (NYSE:AZN) in last trading activity fell -0.58% to close at $71.69. Company weekly performance is -0.15% while its quarterly performance stands at -3.99%. AstraZeneca PLC (NYSE:AZN) is -12.15% away from its 52 week high.
General Motors Co (NYSE:GM) has developed contingency plans in case recalls of potentially lethal Takata-made air bag inflators widens, forcing the U.S. automaker to repair millions of vehicles, the company said on Friday. On last trading day General Motors Company (NYSE:GM) advanced 3.34% to close at $32.81. Its volatility for the week is 2.56% while volatility for the month is 2.20%. GM’s sales growth for past 5 years was 0.90% and its EPS growth for past 5 years was 15.40%. General Motors Company (NYSE:GM) monthly performance is 2.95%.